Episode
Startups are betting on a legalized peptide market
- Podcast
- Marketplace Tech
- Published
- May 26, 2026
- Duration seconds
- 454
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/marketplace-tech-318132/episodes/startups-are-betting-on-a-legalized-peptide-market/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/marketplace-tech-318132/startups-are-betting-on-a-legalized-peptide-market.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Peptides are short chains of amino acids. GLP-1 weight loss drugs are peptides. Insulin is one, too. And there are thousands of others. Now, people are seeking out peptides in the hope of better muscles, better skin, better memory, better…everything. Many of the peptides people wanna try are available for research use only but the Food and Drug Administration might change this. In July, the agency could decide to make about a dozen peptides more accessible by allowing pharmacies to compound and distribute them Marketplace’s Stephanie Hughes spoke with Zara Stone, tech culture reporter at The San Francisco Standard, to learn more.